Labcorp (LH) EVP exercises RSUs and sells 87 shares under 10b5-1 plan

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Jonathan C. Meltzer, EVP, Operations, reported several equity transactions in Labcorp common stock. On February 11, 2026, he acquired 243 shares of common stock through the vesting and conversion of 243 Restricted Stock Units, each RSU representing one share of common stock.

To cover taxes related to this vesting, 70 shares were withheld at a price of $289.89 per share. On February 12, 2026, he executed an open‑market sale of 87 shares at an average price of $290.42 per share under a pre‑arranged Rule 10b5‑1 trading plan. After these transactions, he directly held 2,782.3256 shares of common stock and 2,694 Restricted Stock Units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meltzer Jonathan C

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Operations

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		243	A	(1)	2,939.3256	D
Common Stock	02/11/2026		F(2)		70	D	$289.89	2,869.3256	D
Common Stock	02/12/2026		S(3)		87	D	$290.42	2,782.3256	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			243	(4)	(4)	Common Stock	243	$0	2,694(5)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

4. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

5. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Jonathan C. Meltzer	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did LH executive Jonathan C. Meltzer report?

Jonathan C. Meltzer reported RSU vesting, tax withholding, and a small open-market sale. He exercised 243 Restricted Stock Units into common stock, had 70 shares withheld for taxes, and sold 87 shares the next day under a Rule 10b5-1 trading plan.

How many Labcorp (LH) shares did the EVP, Operations sell in this Form 4?

The EVP, Operations sold 87 shares of Labcorp common stock. The sale occurred on February 12, 2026, at an average price of $290.42 per share, and was executed under a pre-established Rule 10b5-1 trading plan disclosed in the filing’s footnotes.

What equity did Jonathan C. Meltzer acquire through RSUs in this LH filing?

He acquired 243 shares of Labcorp common stock through the vesting and conversion of 243 Restricted Stock Units. Each RSU represents the right to receive one share. These vested units are part of a grant that vests in three equal annual installments beginning February 11, 2026.

How many Labcorp (LH) shares and RSUs does Meltzer hold after the transactions?

After the reported transactions, Meltzer directly holds 2,782.3256 shares of Labcorp common stock. He also holds 2,694 Restricted Stock Units in total, reflecting the aggregate number of RSUs remaining after the 243-unit vesting and related stock tax withholding.

Why were 70 Labcorp (LH) shares withheld in Jonathan C. Meltzer’s Form 4?

Seventy shares were withheld to satisfy tax withholding obligations arising from the RSU vesting. Instead of paying taxes in cash, a portion of the newly delivered shares was retained at $289.89 per share, as noted in the filing’s explanatory footnote.

Was Jonathan C. Meltzer’s Labcorp stock sale under a Rule 10b5-1 plan?

Yes. The Form 4 states the sale was made pursuant to a plan in accordance with Rule 10b5-1. Such pre-arranged trading plans allow insiders to sell shares on a predetermined schedule, helping separate trading decisions from day-to-day corporate information.